Research into bipolar disorder at Oxford has received a major boost following a \u00a33 million donation from the Page family. The legacy gift will support the development of innovative new treatments as well as improved methods of self-management for those with the condition.
Congratulations to Nuffield Department of Surgical Sciences researchers Dr Sandy Figiel and Mr George Adigbli for winning first and second prizes respectively for their poster presentations \u2013 out of 53 entries \u2013 at the Cancer Research UK (CRUK) Oxford Centre 2023 Annual Symposium on Thursday 16 March.
Researchers from King\u2019s College London and University of Oxford have shown that 18.4 per cent of the general UK population report that certain sounds, such as loud chewing, and repetitive sniffing, cause a significant problem in their lives. The condition is known as misophonia.
An analysis of data by researchers at the Nuffield Department of Population Health\u2019s Cancer Epidemiology Unit has shown that use of progestogen-only hormonal contraceptives is associated with a 20-30% higher risk of breast cancer. The results are published in PLOS Medicine.
Clinical researchers have reviewed the international research evidence regarding the impact of viewing images of self-harm on the internet and in social media.
The award reflects the Department\u2019s commitment to representation, progression and success for all. It acknowledges the innovative policies and practices developed across the department and the detailed action plans for improvement.
Chief Medical Officer of England Professor Sir Chris Whitty KCB FMedSci delivers the Sherrington Prize Lecture: Public Understanding of Science to an audience of Oxford staff and students.
Researchers at the University of Oxford in collaboration with 25 teams across the world have published the largest study to date of the genetic basis of endometriosis.
Active monitoring of prostate cancer has the same high survival rates after 15 years as radiotherapy or surgery, reports the largest study of its kind.
Rare Disease Day is an annual awareness day that aims to educate and raise awareness for the 400 million people worldwide who live with a rare disease.
New artificial intelligence software that can help to spot prostate cancer is being trialled by researchers at Oxford University Hospitals (OUH) NHS Foundation Trust.
A new Department of Physiology, Anatomy and Genetics study has revealed key new insights into the role of cAMP signalling in both healthy and disease settings within the heart. Researchers have identified new cAMP nanodomains in cardiac muscle cells that have far reaching implications for the treatment of heart disease.
Collaborative work from Department of Physiology, Anatomy & Genetics (DPAG) and Department of Oncology researchers has revealed a potential new pathway to block the production of a specific group of exosomes made in the cell\u2019s recycling system that can promote the growth of cancerous tumours.
More spinout companies are created by the University of Oxford than any other UK University and an increasing number of their founders and senior leaders are women.
![\"Bipolar](\"https://www.medsci.ox.ac.uk/news/3-million-legacy-gift-to-deliver-significant-benefits-for-people-with-bipolar-disorder/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n